Elite Pharmaceuticals, Inc. Property, Plant and Equipment, Gross
Elite Pharmaceuticals, Inc. (ELTP) had Property, Plant and Equipment, Gross of $29.09 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-13
- 2026-06-30: Property, Plant and Equipment, Gross $29.09M.
- 2026-03-31: Property, Plant and Equipment, Gross $28.28M.
- 2025-12-31: Property, Plant and Equipment, Gross $27.88M.
- 2025-09-30: Property, Plant and Equipment, Gross $27.68M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-06-30 | $29.09M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $28.28M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $27.88M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $27.68M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $27.57M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $27.36M 10-K · filed 2026-06-29 |
| 2024-12-31 | $26.60M 10-Q · filed 2025-02-13 |
| 2024-09-30 | $26.60M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $26.77M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $26.08M 10-K · filed 2025-06-30 |
| 2023-12-31 | $25.67M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $25.01M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $25.01M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $25.01M 10-K · filed 2024-07-01 |
| 2022-12-31 | $24.50M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $24.50M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $19.40M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $19.30M 10-K · filed 2023-06-29 |
| 2021-12-31 | $19.04M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $18.96M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $18.81M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $18.80M 10-K · filed 2022-06-29 |
| 2020-12-31 | $18.62M 10-Q · filed 2021-02-16 |
| 2020-09-30 | $18.44M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $18.37M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $18.18M 10-K · filed 2021-06-14 |
| 2019-12-31 | $18.15M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $18.15M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $18.12M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $18.10M 10-K · filed 2020-06-29 |
| 2018-12-31 | $18.10M 10-Q · filed 2019-02-11 |
| 2018-09-30 | $17.78M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $17.58M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $17.40M 10-K · filed 2019-06-21 |
| 2017-12-31 | $17.26M 10-Q · filed 2018-02-09 |
| 2017-09-30 | $17.10M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $16.93M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $16.47M 10-K · filed 2018-06-14 |
| 2016-12-31 | $15.95M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $15.42M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $15.12M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $14.84M 10-K · filed 2017-06-14 |
| 2015-12-31 | $14.21M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $13.95M 10-Q · filed 2015-12-30 |
| 2015-03-31 | $12.48M 10-K · filed 2016-06-15 |
| 2014-03-31 | $9.71M 10-K · filed 2015-06-15 |
| 2013-03-31 | $9.10M 10-K · filed 2014-06-30 |
| 2012-03-31 | $8.94M 10-K · filed 2013-06-21 |